Thinheal appeared at CPHI2025 to explore new opportunities for innovation and development

From June 24 to 26, 2025, the Shanghai New International Expo Center was bustling with activity, and the spotlight on the global pharmaceutical industry was once again focused on the grand opening of the 23rd World Pharmaceutical Ingredients Exhibition (CPHI 2025). 

As Asia's largest and most influential pharmaceutical industry event, this year's exhibition attracted over 3,000 exhibitors from 120 countries.

 Hangzhou Thinheal Pharma-Tech Co,.Ltd proudly showcased its core peptides, including semaglutide, Tirzepatide, and retatrutide, kicking off this exciting journey of exchange within the peptide industry.

During the exhibition, Xinhai Pharmaceutical's booth was in an excellent location, attracting the attention of a large number of domestic and foreign customers, partners and peers in the peptide industry, and there was an endless stream of people coming to consult and negotiate.

With their solid professional knowledge and good communication skills, the company's elites warmly welcome every visitor, introduce the company's product features, production processes, quality standards and application areas in detail, patiently answer customer questions, and provide personalized solutions based on customer needs, winning high recognition and praise from customers.

Through on-site product introductions, technical explanations and case sharing, customers can have a more intuitive understanding of the advantages and value of peptide products.